title: Rostral-caudal differences in the effects of intra-VTA muscimol on cocaine self-administration.
abstract: We have found that dopamine (DA) in the ventral tegmental area (VTA) plays an important role in cocaine self-administration. DA in the VTA acts at D1-type receptors on the terminals of GABA afferents causing release of this neurotransmitter. Thus, the neurochemical pathways whereby VTA DA might be involved in cocaine self-administration may include GABA neurotransmission. In the present study, we investigated this possibility. Rats were prepared with intravenous catheters and bilateral guide cannulae positioned to allow microinjections directly into the VTA or a site 1 mm dorsal to it. The rats were then trained to self-administer cocaine (1.0 mg/kg/injection) under a fixed-ratio 1 schedule of reinforcement and tested with microinjections of muscimol (0, 0.05 and 0.1 microg/0.25 microl) or picrotoxin (0, 0.025 and 0.05 microg/0.25 microl) or trained under a progressive ratio (PR) schedule and tested with vehicle and 0.05 microg/0.25 microl muscimol. Muscimol in the VTA, but not immediately dorsal to it, significantly reduced cocaine intake under the FR1 schedule. Furthermore, when analyzed by rostral/caudal site of injection, it was found that rostral injections of muscimol significantly reduced cocaine self-administration whereas caudal injections produced non-significant decreases in self-administration. Inspection of individual records revealed no signs of non-specific behavioral effects of the muscimol treatments. Muscimol in the rostral VTA also significantly increased break points in responding under the PR schedule. Intra-VTA picrotoxin did not significantly affect cocaine self-administration. These data suggest that stimulation of GABA-A receptors in the VTA is involved in cocaine self-administration and reward and that this involvement is more pronounced in the rostral than in the caudal VTA.
authors.affiliation: Department of Psychology, Queens College, City University of New York, Flushing, NY 11367, USA.
authors.forename: David Y
authors.initials: DY
authors.lastname: Lee
authors.forename: Matthew
authors.initials: M
authors.lastname: Guttilla
authors.forename: Kinsun D
authors.initials: KD
authors.lastname: Fung
authors.forename: Stacey
authors.initials: S
authors.lastname: McFeron
authors.forename: Jerry
authors.initials: J
authors.lastname: Yan
authors.forename: Robert
authors.initials: R
authors.lastname: Ranaldi
mesh_terms: D000818:Animals; D003042:Cocaine / Q000008:administration & dosage*; D019970:Cocaine-Related Disorders / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology; D018755:GABA Agonists / Q000008:administration & dosage; D008297:Male; D008845:Microinjections; D009118:Muscimol / Q000008:administration & dosage*; D051381:Rats; D020318:Rats, Long-Evans; D011963:Receptors, GABA-A / Q000502:physiology; D012054:Reinforcement, Psychology; D012646:Self Administration; D017557:Ventral Tegmental Area / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology*
chemical_list: D018755:GABA Agonists; D011963:Receptors, GABA-A; D009118:Muscimol; D003042:Cocaine; D004298:Dopamine